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Abstract
Background: Preventive activities carried out in primary care have important variability that
makes necessary to know which factors have an impact in order to establish future strategies for
improvement. The present study has three objectives: 1) To describe the variability in the
implementation of 7 preventive services (screening for smoking status, alcohol abuse, hypertension,
hypercholesterolemia, obesity, influenza and tetanus immunization) and to determine their related
factors; 2) To describe the degree of control of 5 identified health problems (smoking, alcohol
abuse, hypertension, hypercholesterolemia and obesity); 3) To calculate intraclass correlation
coefficients.
Design: Multi-centered cross-sectional study of a randomised sample of primary health care teams
from 3 regions of Spain designed to analyse variability and related factors of 7 selected preventive
services in years 2006 and 2007. At the end of 2008, we will perform a cross-sectional study of a
cohort of patients attended in 2006 or 2007 to asses the degree of control of 5 identified health
problems. All subjects older than16 years assigned to a randomised sample of 22 computerized
primary health care teams and attended during the study period are included in each region
providing a sample with more than 850.000 subjects. The main outcome measures will be
implementation of 7 preventive services and control of 5 identified health problems. Furthermore,
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attendance); 2) Health-care professional level (professional characteristics, years working at the
team, workload); 3) Team level (characteristics, electronic clinical record system). Data will be
transferred from electronic clinical records to a central database with prior encryption and
dissociation of subject, professional and team identity. Global and regional analysis will be
performed including standard analysis for primary health care teams and health-care professional
level. Linear and logistic regression multilevel analysis adjusted for individual and cluster variables
will also be performed. Variability in the number of preventive services implemented will be
calculated with Poisson multilevel models. Team and health-care professional will be considered
random effects. Intraclass correlation coefficients, standard error and variance components for the
different outcome measures will be calculated.
Background
The Spanish National Health Service (NHS) provides uni-
versal cover and is financed, essentially, by general taxes.
The system is divided into primary and secondary care.
Primary care (PC) is organized as a network of primary
health care teams (PHCT) that behave as geographical and
administrative units where PC services are planned, man-
aged and provided for a population ranging from 5,000 to
25,000 citizens. The PHCT staff includes: general practi-
tioners (GPs), paediatricians, nurses, social workers, den-
tists and ancillary staff. GPs care for individuals older than
14 years (except in rural areas where they look after all
members of the local population) and paediatricians look
after those between 0 and 14 or 16 years, depending on
the region. These clinicians act as gate-keepers for the rest
of the public health care system. The PHCT works usually
in a single health care centre but in rural areas there may
have other small offices.
Secondary care includes out-patient and in-patient hospi-
tal care and out-patient care in multi-disciplinary clinics.
The Spanish NHS has been strongly decentralized into 17
Autonomous Communities or regions that configure the
Spanish State. Each of these regions has its own govern-
mental structure which, among other responsibilities,
provides health-care services to the population. There are
minor differences between them with respect to structure
and administration. For example, in Aragon and Navarra
all services are provided by the State-funded regional serv-
ice while in Catalonia, the provision of primary care serv-
ices is offered by different providers (state and non-state
funded) among which the Catalan Health Institute (ICS)
manages almost 80% of all PHCT. According to latest cen-
sus of the year 2002, Aragon had a population of
1,209,888 inhabitants while Navarra had 560,235 inhab-
itants and Catalonia 6,418,387.
Preventive services in Primary Care
PC is the most accessible health-care level to the general
population. In Spain, more than 95% of the population
visit their GP at least once in every 5 years. No other
health-care level is in a better position to evaluate the glo-
bal health status of the individual and to decide when to
act and what are the ideal measures to take in each specific
situation [1].
There is an increasing evidence of the health benefits
achieved from the implementation of preventive meas-
ures in normal clinical practice. In the last quarter of the
century several groups of experts such as the Canadian
Task Force on Periodic Health Examination in 1979 [2]
and the US Task Force in 1980 [3,4] have published evi-
dence-based recommendations regarding the relevance
and the outcomes of the implementation of preventive
interventions. Prestigious institutions such as WHO and
the Royal College of General Practitioners [5] have high-
lighted the valuable role of health-care professionals
within PCHTs in developing these services.
In Spain, the Spanish Society of Family and Community
Medicine [Sociedad Española de Medicina de Familia y
Comunitaria; semFYC] launched in 1988 the Preventive
Activities and Health Promotion Program [Programa de
Actividades Preventivas y de Promoción de la Salud; PAPPS]
that have as main objective promoting the implementa-
tion of preventive and health promotion services in PC
[6]. The EUROPREV (European Network for Prevention
and Health Promotion in Family Medicine and General
Practice) was created to extend and coordinate the experi-
ences from this program and to promote preventive serv-
ices at the European level.
In the period between 1989 and 2003 PAPPS program car-
ried out biennial evaluations of a representative sample of
patients attending the PHCTs participating in the program
(671 PHCT since the beginning of the program). These
evaluations have been the only evaluations of preventive
services carried out nation-wide and provide information
on the progress and effectiveness of the program over its
15 years of existence [7-9]. From the studies we know that
the best-implemented group of preventive services is thePage 2 of 8
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includes screening for hypertension, smoking status and
alcohol consumption (done in 92.8% of patients), fol-
lowed by a second group that includes anti-influenza vac-
cination, screening for hypercholesterolemia and obesity
and anti-tetanus vaccination (done in more than 70% of
patients) [8].
However, the progressive implementation of systematic
evaluations of primary care performance promoted by the
Autonomous health administrations and the progressive
computerization of clinical records has brought-about a
re-thinking of this evaluation model. The computeriza-
tion of clinical records provides rich information based
on individual data (not centre aggregated data) on a wider
and more representative sample that avoids manual and
voluntary recording of data. This allows a better study of
the clinical practice variability (CPV) and its determining
factors.
Clinical practice variability in preventive services in 
Primary Care
In Spain, there have been few nation-wide population
studies evaluating CPV in PC. This has been due, in part,
to the lack of reliable information systems. These studies
have often been performed at a hospital level because of
the existence of minimum basic data sets (MBDS) pro-
vided on discharge from hospital. Nevertheless, from the
existing evaluations, PAPPs studies [8,9] and other
national [10-13]and international [14-16] studies it is
clear that there are important difficulties with respect to
the correct implementation of preventive services and
health promotion interventions and there is a high varia-
bility in their implementation. There is extensive literature
on factors related to prevention of specific diseases but
less related to implementation of a combination of pre-
ventive services as routine clinical practice in PC that may
have a profound effect on different diseases. These factors
vary considerably, depending on the type of study, the
country and type of preventable disease. There are differ-
ent factors associated with the supply and demand of serv-
ices that result in elevated variability between and within
centres: patient-related factors (socio-demographic and
clinical factors), health professional associated factors
(specialty, training and professional competence, number
of years working with the PHCT), team related factors
(existence of specific registries, workload, frequency of
doctors encounters, teaching centre) and other health-
care provision system characteristics [12].
High CPV translates into problems of clinical effectiveness
and social efficiency in health-care provision and, as such,
is of concern to health-care providers and to Society in
general [17,18]. An analysis of CPV is therefore essential
in decision making in the health-care provision politics
and prioritization in clinical management (e.g. to gener-
ate guidelines for implementation in those areas of high
clinical variability).
Hence, it is essential to have studies that include a terri-
tory-wide sampling in order to achieve greater representa-
tiveness and which take into account methods of design
and statistical analysis (e.g. cluster-based analyses) to
obtain valid estimates and to explore the influence of
patient, health-care professional and PHCT characteristics
on the CPV of preventive services in Spain.
Sources of information in Primary Care: the 
computerization of clinical records
Primary Care uses electronic clinical records (ECRs) to
monitor health problems and to register preventive care
services. Although information collection intends to be
comprehensive, the ECR systems are different for each
region.
Routinely-collected data have undisputed advantages in
the study of CPV; they are available almost instantane-
ously and provide information on a large number of
patients. The creation of registries or databases of health-
care interest in PC was given a considerable boost with the
computerization of clinical records. Spain, contrary to
other countries [19-23], has little experience in the use of
nation-wide databases containing electronic clinical
records in PC. Recently, projects such as the BIFAP project
in pharmacoepidemiological research [24]http://
www.bifap.org have been initiated in Spain.
However, there are certain difficulties in their use: 1) The
data was originally collected for a function different from
current research requirements; 2) ECR systems are differ-
ent in each region, with different standards and computer
programs; 3) The heterogeneous degree of implementa-
tion in PHCTs; and 4) The degree of exhaustivity of data
recorded (for example, some activities are carried out but
are not registered). Nevertheless, the potential of this type
of registry has been confirmed by different European
experiences mentioned earlier [25-27]. As such, the
advantages associated to computerization of clinical
records are beginning to be appreciated by the different
regions and the richness of information provides enor-
mous potential for the study of CPV in primary care.
Intraclass correlation coefficient
Reports of cluster randomised studies [28] should include
sample size calculations and statistical analyses that take
clustering into account. The intraclass correlation coeffi-
cient (ICC) is a measure of the relatedness of clustered
data [29]. Compared with individual randomisation,
cluster randomisation may substantially increase the sam-Page 3 of 8
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[30].
One of the problems that needs to be faced in designing
cluster-based studies (area or organization-based studies)
is that estimates of ICC and components of variance for
the outcomes of interest need to be obtained from previ-
ous studies in order to determine the required sample size
for the cluster design [30-32]. There have been repeated
calls for publication of ICCs for these types of studies to
help others who are planning cluster-based studies
[29,33-35].
The differences [30] in ICCs among potential outcome
variables, the paucity of appropriate information [36]
concerning components of variance or ICC and the lack of
data obtained from PC settings reinforce the need for
valid estimates that would ensure proper study design.
Study objectives
The planned objectives in the present study are:
- To describe the variability in the performance of 7 pre-
ventive services (detection of smoking status and excessive
alcohol consumption; screening for hypertension, obesity
and hypercholesterolemia; anti-influenza and anti-teta-
nus immunization) in a population older than 16 years of
age receiving attention in years 2006 or 2007 and to ana-
lyse factors related to their implementation.
- To analyse the evolution of 5 identified health problems
(decrease in consumption or abstention from tobacco and
alcohol and degree of control of hypertension, hypercho-
lesterolemia and obesity) up to December 2008 in the
population older than16 years of age attended by the ref-
erence PHCT at least once between 2006 and 2007 and
followed up during 2008.
- Estimate the ICC, together with the within-cluster and
between-cluster components of variance for each of the
outcome measures of interest at the PC level.
Methods/Design
Design
This is a multi-centered cross-sectional study of a ran-
domised sample of PHCT stratified by region to describe
the variability in the implementation of 7 preventive serv-
ices and their related factors in the period of 2006 or
2007. In 2008, using another cross-sectional study, the
evolution or degree of control of 5 of the identified health
problems will be assessed, together with the determinants
of variability. We use a longer period of study because we
need more time to evaluate the impact on the degree of
control of these health problems due to changes on life
styles.
Setting
The study is set in PHCTs computerized prior to 1st of Jan-
uary 2005 in the regions of Aragón, Navarra, and Catalo-
nia. So far computerization had occurred in 19% of 121
PHCTs in Aragón, 76% of 54 PHCTs in Navarra, and
97.5% of 278 PHCTs in Catalonia (at the Catalan Health
Institute).
Study population: PHCT and patients
We performed random cluster sampling stratified by
region with computerized PHCT used as unit of randomi-
sation.
The inclusion criteria of the PHCT are: 1) computerization
of the clinical records before the 1st of January 2005 to
ensure familiarity with the system's use; 2) wide use of
ECR, and 3) agreement to participate in the study by most
of the health-care professionals working in each PHCT (>
80%).
For each computerized PHCT we select the ECRs of all
subjects older than16 years as the unit of data collection.
For the assessment of variability, the ECR of subjects
receiving attention at least once in each of the study years
will be extracted from the database. It is estimated that the
average number of subjects receiving attention per year is
around 70%. Thus in a PHCT in Aragon this figure would
be around 10,000 patients, in Navarra around 7,500 and
in Catalonia around 12,000. For the analysis of the evolu-
tion of health problems and related factors, subjects vis-
ited at least on one occasion during the 2006–2007
period and on a further occasion in 2008 will be included.
Sample size and randomisation
To achieve the equivalent power of a patient-randomised
design, in a cluster randomised design the effective sam-
ple size will need to be the standard sample size of a single
random sampling multiplied by the design effect
[31,37,38]. The design effect is a function of the average
cluster (computerized PHCT) size and the (intraclass cor-
relation coefficient (ICC) of the outcome:
design effect = 1 + (n-1)*ICC
where n is the average number of individuals sampled per
cluster [38].
sWith the cluster design we set an ICC of 0.05 on the
assumption that the ICCs estimated for outcome variables
from PC are less than 0.05 [28,36,39] and that the average
number of individuals sampled per centre is at least of
2,500. Therefore 20 computerized PHCTs are necessary
from each region to guarantee a statistical power of 80%,
assuming a 50% event rate with an alpha two-tailed signif-
icance level of 0.05. Finally, to allow any of the ran-Page 4 of 8
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participate, we increased the number of computerized
PHCTs selected from each region to 22. As such, the total
number of subjects included will be more than 300,000 in
Aragón, 200,000 in Navarra and 350,000 in Catalunya i.e.
more than 850,000 subjects in total. This volume of sub-
jects ensures a good estimate of the different outcome
measures in the sub-groups of each cluster.
The selection of computerized PHCT to participate in the
study is by a simple random sample within each region.
Sample size calculation and computerized PHCT selec-
tion is performed with Epidat 3.1.
Outcomes and others measures
Primary outcome measures
The primary outcome measures relating to objective 1
include the description of the implementation of preven-
tive services according to the PAPPS criteria [6].
Screening for smoking status: if there is information on
the consumption of tobacco over the last two years in
members of the population who previously were non-
smokers.
Screening for excessive alcohol consumption: if there is
information on the consumption of alcohol over the last
two years in members of the population who previously
were not high consumers of alcohol.
Screening for obesity: if there have been measurements of
height and weight or body mass index (BMI) over the last
4 years in members of the population who previously
were non-obese.
Screening for hypertension: if there is information on
systolic blood pressure (BPS) and diastolic blood pressure
(BPD) during the last 4 years in members of the popula-
tion aged between 16 and 40 years who previously did not
have the diagnosis of hypertension; or over the past 2
years in members of the population older than 40 years
who previously did not have the diagnosis of hyperten-
sion.
Screening for hypercholesterolemia: if there is informa-
tion on total blood cholesterol corresponding to the fol-
lowing criteria of age and gender: 1 measurement in males
between 16–35 years old; 1 measurement in females
between 16–45 years old; 1 measurement every 5 years in
males between 35–75 years old; 1 measurement every 5
years in females between 45–75 years old; 1 measurement
if there has not been a previous measurement in those
older than 75; all of these performed in population that
previously did not have the diagnosis of hypercholestero-
lemia.
Anti-tetanus vaccination (ATV): if there is a registry of
anti-tetanus vaccination over the previous 10 years.
Anti-influenza vaccination (AIV): if there is a registry of
annual anti-influenza vaccination in those older than 59
years of age.
The primary outcome measures relating to objective 2
describes the clinical follow-up of the five health prob-
lems identified up to December 31st 2007 and evaluated
up to December 31st 2008:
Evolution of tobacco consumption: quit smoking or
remaining an ex-smoker.
Evolution of excessive alcohol consumption: cessation of
consumption or decrease below the definition of excessive
consumption (28 alcohol units/week in males and 17
alcohol units/week in females, where 1 alcohol unit = 10
grams of alcohol).
Evolution of obesity: decrease in BMI to <30 kg/m2 or
change in the diagnosis to non-obese.
Evolution of hypertension: mean of the last 2 determina-
tions of systolic BP/diastolic BP registered as being ≤ 130/
80 mmHg in patients of high risk (diagnosed with diabe-
tes, renal or cardiac insufficiency) and ≤ 140/90 mmHg in
the rest of the population.
Evolution of hypercholesterolemia: last measurement of
LDL cholesterol registered as being ≤ 100 mg/dL in high-
risk patients (diagnosed with diabetes, ischaemic heart
disease or cerebrovascular accident) and ≤ 130 mg/dL in
the rest of the population.
Secondary outcome measures
Number of different preventive services (among the 7 of
the study) registered for each individual during the 2006
and 2007 year periods.
Other measures
We assess the following factors related to the outcome
measures according to the levels of analysis:
Computerized PHCT: variables of structure and organiza-
tion of the PHCT (number of GPs and nurses, presence of
specialists), adherence to PAPPS, training centre for fam-
ily doctors, ECR system and starting year, assigned popu-
lation.
Health-care professionals (GPs, nurses): gender, age, spe-
cialty, years of employment in PC and in the PHCT, work-
load (mean number of visits/day), years of experience
with ECR.Page 5 of 8
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Adjusted Clinical Groups grouper [40,41], frequency of
consultations (visits/year).
Information source
The individual data will be extracted directly from the cen-
tral computer servers of the ECRs of the subjects included
in the study. In Navarra and Aragón the system used is
OMI-AP and in Catalonia the eCAP system. The data
related to health-care professionals and to PHCT will be
obtained from an on-line database for health-care profes-
sionals and from a person responsible in each centre.
Data extraction and processing
Using the specific interface for each specific computer sys-
tem (OMI-AP and eCAP), each region will extract the
study data and transfer them to a central database where
they will be homogenized and processed into a specially-
constructed final database.
Confidentiality of data
Data confidentiality will be assured during and subse-
quent to the extraction using encryption and dissociation
of the individual's identification, health-care profession-
als, and of PHCTs.
Ethical aspects
The study has been favourably evaluated by the Research
Committee of the IDIAP Jordi Gol.
Quality control
Quality controls will be carried out in the 2 extractions of
data comparing agreement between the central database
and the original data of some centres as for: number of
patient, visits and diagnoses as well as data of prevalence
of certain diseases. It will also be checked if the popula-
tion data is appropriate by comparing it with data from
the census and other official sources. In the case of items
related to clinical activities (for example blood pressure
measurement), any register with missing values will be
considered as not performed.
Statistical analyses
For the first two objectives all the analyses will be per-
formed on a global level and each region separately. Clus-
ter level analysis (computerized PHCT and health-care
professional) will be performed using standard paramet-
ric or non-parametric analytical methods, with cluster
means or proportions as observations [37,42]. For the
adjusted analysis we will perform regression analysis of
individual level data using methods for clustered data,
multilevel, hierarchical or random effects models [37,43].
This methodology facilitates simultaneous analyses of the
effects of individual and cluster variables in order to eval-
uate whether the relationship between variables at the
individual level varies in accordance with the characteris-
tics of the cluster and whether the individual and cluster
variability can be attributed to factors of the cluster and/
or to the factors related to the individual. Analysis will be
performed at 3 levels: PHCT, health-care professional and
individual subjects.
Multilevel linear (for continuous outcome variables) or
logistic (for dichotomous outcome variables) regression
analyses will be performed for the first two objectives. The
analyses will be adjusted for explanatory factors at indi-
vidual, health-care professional and PHCT level and for
other variables that are clinically relevant. We will also
adjust for possible confounders checking whether they
will affect the outcomes. A nested or hierarchical structure
will be considered: the attended individuals are nested
within the health-care professional and the health-care
professional within PHCT. The PHCT and the health-care
professional will be considered random effects.
Multilevel Poisson regression models will be used to eval-
uate the number of preventive activities recorded for each
individual.
For the third objective, the ICCs, their standard errors and
the components of variance [36,37,42,43] for the differ-
ent outcome measures will be calculated using methods
that enable adjustment for covariables, together with ran-
dom effect methods (health-care professionals and
PHCT). Initially, we will estimate the coefficients of vari-
ance and ICCs using the outcome as the dependent varia-
ble and the health-care professional/PHCT as random
effects. Subsequently, we will perform an adjusted analy-
sis for the characteristics of the individual, the health-care
professional and the PHCT.
We will study interactions and collinearity. The collinear-
ity of the maximal models will be evaluated using the cri-
teria proposed by Belsley [44]. We will set the significance
level at 1% (two-tailed).
Analysis will be carried out using the SPSS statistical pack-
age for Windows, version 15 (SPSS Inc., Chicago, IL) and
the SAS package 9.1.3 for Windows (SAS Institute Inc.,
Cary, NC, USA).
Discussion
The project results will provide very useful information on
the degree of registration and performance of the 7 pre-
ventive services selected. These 7 activities have been
widely implemented and have a high impact on the
health of our population [2-6]. The large population data-
base of the study, with more than 850,000 people
recorded, will increase considerably the external validityPage 6 of 8
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Primary Care settings in the Spanish NHS.
This fact may help to overcome the current limitations
and to investigate CPV and the factors that have an impact
on the implementation of preventive services.
Certainly the source of information used and the ECRs
may have limitations. The heterogeneity of current com-
puter systems may complicate the extraction of outcomes
and of variables. However, the design of the data extrac-
tion interfaces and data transfer will minimize the prob-
lems. The lack of exhaustivity in data recording may
introduce some distortions in the information. Neverthe-
less, stability of computer systems at the centres will help
to minimize this problem and the quality control meas-
ures will help to identify the magnitude of the problem.
Studies based on cluster sampling allow important reduc-
tion in costs and greater easiness in administration but
require knowledge of the ICCs. For this study ICCs has
been estimated from studies conducted in other countries.
In our study we will provide information concerning the
magnitude of the ICC, evaluate factors that influence their
magnitude, estimate within-cluster and between-cluster
components of variance for the outcome measures under
consideration and determine the sample size; all of these
factors will aid the design and statistical analysis of future
cluster-based studies set in PC.
In conclusion, the present study will provide new knowl-
edge in:
- The identification of factors related to the variability in
the implementation of preventive services, which will
facilitate the design of strategies for improvement in the
planning and administration of services in PC.
- The assessment of the evolution of the detected health
problems will improve the degree of existent evidence tak-
ing into account the results of screening and the control of
those problems. This will be very useful for the evaluation
of the PAPPS and other studies based on this source of
information.
- The estimation of the ICC will be of considerable help in
the design, calculation of sample size and analysis of
future studies based on the randomisation of clusters in
our environment.
- Finally, although not being an aim of the project, infor-
mation will be obtained on the characteristics of the dif-
ferent computer systems and this information will
generate recommendations for the standardization of sys-
tems for future applications.
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